Researchers mapped gene enhancers contributing to skull and face development; we’re closer to isolating causes of craniofacial defects like cleft palate.
Cancer Research: Attacking Brain Tumors With Epigenetic and Drug Therapy
Defective Signaling Pathways: The Big Picture in Cancer
Cancer Treatment Gets Huge Nudge From Blind Mole Rats?
Blind mole rats’s adaptation to stressors like hypoxia, through modified genes, have enabled them to stave off cancer. Could spalax help people do the same?
Prostate Cancer: New insights from lncRNA world
Upregulated expression of long non-coding RNAs, PCGEM1 and PRNCR1, in prostate cancer, alters gene expression of androgen receptor’s target genes.
Enhancer RNAs (eRNAs) New Targets for Gene Therapy?
There’s a new type of gene therapy: Suppressing non-coding RNA, or eRNA. is the primary target in treatment of disease-causing genes.